Plasma neutrophil gelatinase-associated lipocalin as a potential predictor of adverse renal outcomes in immunoglobulin A nephropathy|RISS 상세보기

다국어 초록 (Multilingual Abstract)

Background/Aims: Neutrophil gelatinase-associated lipocalin (NGAL) is a wellknown biomarker of acute kidney injury. We evaluated the value of plasma NGAL (pNGAL) as an independent predictor of prognosis in immunoglobulin A nephropathy (IgAN).
Methods: In total, 91 patients with biopsy-proven IgAN at a single center were evaluated. pNGAL was measured using a commercial enzyme-linked immunosorbent assay kit (R&D Systems). Adverse renal outcome was defined as chronic kidney disease (CKD) stage 3 or above at the last follow-up. Pearson correlation coefficient and Cox regression were used for analyses.
Results: The mean age of all patients (male:female, 48:43) was 35 years (range, 18 to 77). pNGAL ranged between 21.68 and 446.40 ng/mL (median, 123.97) and showed a correlation with age (r = 0.332, p = 0.001), creatinine (r = 0.336, p = 0.001), estimated glomerular filtration rate (r = –0.397, p < 0.001), uric acid (r = 0.289, p = 0.006), and the protein-to-creatinine ratio (r = 0.288, p = 0.006). During a mean follow-up period of 37.6 months, 11 patients (12.1%) had CKD stage 3 or above. In a multivariate Cox regression model, hypertension (hazard ratio [HR], 8.779; 95% confidence interval [CI], 1.526 to 50.496; p = 0.015), proteinuria > 1 g/day (HR, 5.184; 95% CI, 1.124 to 23.921; p = 0.035), and pNGAL (HR, 1.012; 95% CI, 1.003 to 1.022; p = 0.013) were independent predictors associated with adverse renal outcome.
Conclusions: pNGAL showed strong correlations with other clinical prognostic factors and was also an independent predictor of adverse renal outcome. We suggest pNGAL as a potential predictor for prognosis in IgAN, while further studies are needed to confirm the clinical value.

번역하기

참고문헌 (Reference)

1 Levy M, "Worldwide perspective of IgA nephropathy" 12 : 340-347, 1988

2 Ding H, "Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy" 123 : 227-234, 2007

3 Phillips AO., "The role of renal proximal tubular cells in diabetic nephropathy" 3 : 491-496, 2003

4 Nielsen SE, "The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP" 72 : 137-142, 2012

5 Li PK, "Prognostic indicators of IgA nephropathy in the Chinese: clinical and pathological perspectives" 17 : 64-69, 2002

6 D’Amico G, "Prognostic indicators in idiopathic IgA mesangial nephropathy" 59 : 363-378, 1986

7 Radford MG Jr, "Predicting renal outcome in IgA nephropathy" 8 : 199-207, 1997

8 Xie J, "Predicting progression of IgA nephropathy: new clinical progression risk score" 7 : e38904-, 2012

9 Bartosik LP, "Predicting progression in IgA nephropathy" 38 : 728-735, 2001

10 Bolignano D, "Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease" 31 : 255-258, 2008